CEO was about to leave or that the company could be taken over, with U.S. healthcare firm Johnson & Johnson (JNJ.N: Quote, Profile, Research, Stock Buzz) (J&J) named as one candidate. J&J declined to comment. The Nobel Biocare spokesman said Scala had to...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 1-Nobel Biocare says talk of CEO change unfounded
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account